Cases & Deals

Auriga Partners and Kreaxi invest in Nosopharm

Clients Auriga Partners and Kreaxi

Jones Day represented Auriga Partners and Kreaxi in connection with their investment in Nosopharm, a France-based biotechnology company specialized in the research and development of new antimicrobial molecules. Alto Invest acted as co-investor in the investment round.